Allan Struthers graduated MB (Hons) from Glasgow University UK in 1977. After junior hospital posts, he was Senior Registrar at the Royal Postgraduate Medical School and Hammersmith Hospital in London in 1982 – 1985. He was then appointed Wellcome Senior Lecturer/Consultant Physician in Dundee and is currently Professor of Cardiovascular Medicine and runs the Heart Failure service at Ninewells Hospital in Dundee. He is also an Honorary Professor at St Andrews University Medical School. He was Chairman of the SIGN Guidelines in Heart Failure twice (2007 and 2016) and Chairman of NHS-QIS Standards (2010) for Heart Failure. In addition, he is also Chairman of Tenovus NSAC, Senior Regional Advisor for SACDA and Council member of Chest, Heart and Stroke Scotland. He is currently Co-Head of the Division of Molecular and Clinical Medicine at the Medical School in the University of Dundee. Professor Struthers runs a large clinical research programme and has supervised 50 MD/PhDs.

Struthers AD. A New Approach to Residual Risk in Treated Hypertension : 3P Screening. HYPERTENSION. 2013, 62 (2), 236-9 Szwejkowski BR, Gandy SJ, Rekhraj S, Houston JG, Lang CC, Morris AD, George J, Struthers AD. Allopurinol reduces Left Ventricular Mass in Patients with Type2 Diabetes and Left Ventricular Hypertrophy. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2013 07.074(e-published ahead of print) Rekhraj S, Gandy SJ, Szwejkowski B, Nadir MA, Noman A, Houston JG, Lang CC, Struthers AD. High dose allopurinol reduces left ventricular mass in patients with ischaemic heart disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2013, 61 (9), 926-932 Anderson W, Lipworth BJ, Rekhraj S, Struthers AD, George J. Left Ventricular Hypertrophy in Chronic Obstructive Pulmonary Disease without Hypoxaemia : The Elephant in the Room? CHEST 2013, 143(1),91-97 Nadir MA, Rekhraj S, Wei L, Lim TK, Davidson J, MacDonald TM, Lang CC, Dow E, Struthers AD Improving the Primary Prevention of Cardiovascular events by using Biomarkers to identify Individuals with Silent Heart Disease. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2012 Sep 11;60(11):960-8. Impact Factor 14.3 Kao MP, Ang DS, Gandy SG, Nadir A, Houston JG, Lang C, Struthers AD. Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2011, 22, 1382 – 1389. (Impact Factor 8·3). Nadir MA, Wei L, R, Elder D, Libianto R, Lim TK, Pauriah M, Pringle SD, Doney AD, Choy AM, Struthers AD, Lang CC. Impact of renin angiotensin system blockade therapy on outcome in aortic stenosis. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2011, 58 (6), 570 – 576. (Impact Factor 14·3). Elder DH, Wei L, Szwejkowski BR, Libianto R, Nadir A, Pauriah M, Rekhraj S, Lim TK, George J, Doney A, Pringle SD, Choy AM, Struthers AD, Lang CC. The Impact of Renin Angiotensin Aldosterone System Blockade on Heart Failure Outcome and Mortality in Patients identified to have Aortic Regurgitation: A Large Population Cohort Study. J AMERICAN COLLEGE OF CARDIOLOGY 2011, 58 (20), 2084 – 2091.(Impact Factor 14·3). Noman A, Ang DSC, Ogston SA, Lang CC, Struthers AD. Effect of high dose allopurinol on exercise in patients with chronic stable angina: A randomised placebo controlled crossover trial. LANCET 2010, 375: 2161-2167. (Impact Factor 34). : Also as BMJ Shortcut. BMJ 2010, 340, p1331. Also as Lancet podcast. Wei L, Struthers AD, Fahey T, Watson AD, MacDonald TM. Spironolactone use and renal toxicity: a population based longitudinal analysis. BRITISH MEDICAL JOURNAL 2010, 340: C1768. (Impact factor 13·5) AlZadjali MA, Godfrey V, Khan F, Choy AM, Doney AS, Wong AK, Petrie J, Struthers AD, Lang CC. Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2009, 53: 747-753. Struthers AD, Lang CC. The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent “pancardiac” target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidneys. EUROPEAN HEART JOURNAL 2007, 28: 1678-1682. (Impact Factor 10) Sumukadas D, Witham MD, Struthers AD, McMurdo M. Effect of perindopril on physical function in elderly people with functional impairment: a randomised controlled trial. CANADIAN MEDICAL ASSOCIATION JOURNAL 2007, 177(8): 867-874. Impact Factor of journal 9 This paper won the Bruce P Squires Award. George J, Carr EA, Davies JI, Belch JJF, Struthers AD. High dose allopurinol improves endothelial function by profoundly reducing oxidative stress and not by lowering uric acid. CIRCULATION 2006, 114: 2508-2516. Struthers AD, Morris AD. Screening for and treating left ventricular abnormalities in diabetes: a promising new way of reducing cardiac deaths. LANCET 2002; 359: 1430-1432 (Viewpoint article) Farquharson CAJ, Struthers AD. Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2002; 39: 767-775. Farquharson C, Butler R, Hill A, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. CIRCULATION 2002; 106: 221-226. Yee KM, Pringle SD, Struthers AD. Circadian influence of aldosterone blockade on QT dispersion and Heart Rate Variability in Chronic Heart Failure. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001) 37, 1800-1807. Farquharson C, Struthers AD. Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction and suppresses vascular angiotensin I/II conversion in patients with chronic heart failure. CIRCULATION (2000); 101: 594-597. Brief Rapid Communication.,